Table 3.
The distribution of the rs2230806 polymorphism in subjects with Alzheimer's disease and control subjects.
| # | # AA | # AG | # GG | freq. A | freq. G | AD vs. Control | ||
| Total | AD | 1225 | 81 | 476 | 668 | 0.260 | 0.740 | p = 0.76 |
| n = 2656 | Control | 1431 | 105 | 548 | 778 | 0.265 | 0.735 | |
| E3/E3 | AD | 437 | 31 | 170 | 236 | 0.265 | 0.735 | p = 0.93 |
| n = 1316 | Control | 879 | 63 | 351 | 465 | 0.271 | 0.729 | |
| E4/E3 | AD | 555 | 32 | 227 | 296 | 0.262 | 0.738 | p = 0.10 |
| n = 832 | Control | 277 | 18 | 92 | 167 | 0.231 | 0.769 | |
| E4/E4 | AD | 125 | 8 | 40 | 77 | 0.224 | 0.776 | p = 0.86 |
| n = 150 | Control | 25 | 1 | 9 | 15 | 0.220 | 0.780 | |
| Females | AD | 267 | 26 | 105 | 136 | 0.294 | 0.706 | p = 0.99 |
| n = 505 | Control | 238 | 23 | 94 | 121 | 0.294 | 0.706 |
p values are caculated by Chi Square tests with 2 degrees of freedom